Axon Enterprise, Inc.
—- Market cap
- —
- Debt
- +$1.89B
- Cash
- −$1.20B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AXON stock price vs MCHP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MCHP's multiple
Needs MCHP P/E.
Implied fair value · at AXON's multiple
Needs AXON P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Axon Enterprise, Inc. · implied price per share
Bear
$20.24
Base
$24.20
Bull
$29.36
MICROCHIP TECHNOLOGY INCORPORATED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TYLER TECHNOLOGIES INC
AXON vs TYL
TELEDYNE TECHNOLOGIES INC
AXON vs TDY
LOCKHEED MARTIN CORP
AXON vs LMT
GENERAL DYNAMICS CORP
AXON vs GD
HUNTINGTON INGALLS INDUSTRIES, INC.
AXON vs HII
Howmet Aerospace Inc.
AXON vs HWM
INTEL CORP
AXON vs INTC
TEXAS INSTRUMENTS INC
AXON vs TXN
ADVANCED MICRO DEVICES INC
AXON vs AMD
QUALCOMM INC/DE
AXON vs QCOM
APPLIED MATERIALS INC /DE
AXON vs AMAT
SKYWORKS SOLUTIONS, INC.
AXON vs SWKS
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe AXON can sustain 30%+ revenue growth while converting that growth into positive operating margins, then holding or adding may be justified because the market is already pricing in a premium growth profile; otherwise, the rich P/S and EV/EBITDA multiples suggest limited valuation upside versus MCHP.
AXON’s current price of $527.76 sits just 3.4% below the P/E-implied value of $509.90, so the valuation gap is small. The comparison looks mixed because AXON trades at much richer sales and EBITDA multiples than MCHP despite similar net margins and stronger top-line growth.
Supporting Metrics